Minute Insight: Stryker Partners With Microbot To Create Liberty Neurointervention Robot

The companies announced a strategic collaboration to integrate Stryker’s neurovascular instruments with Microbot’s Liberty robot to create procedure kits specifically for neurovascular interventions.

Minute Insight
• Source: Pharma Intelligence / Alamy

Stryker has agreed to work with Microbot Medical Inc. to develop the world’s first robotic procedure kits for neurovascular interventions.

Microbot was founded in Israel in 2010 by medtech entrepreneur Yossi Bornstein, who co-founded XACT Robotics, and engineer Moshe Shoham, who co-founded Mazor Surgical – now part of Medtronic

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Minute Insights

More from Medtech Insight

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By 

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.